NCT07293065: A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell)
- State
- Under way
- Phase
- Phase 3
- People
- 12,000 planned
- Started
- 15 Dec 2025
- Primary completion
- 31 Dec 2027
- Arms
- Vaccine Group
- Results
- None posted
- 15 Dec 2025: Trial started
- 18 Dec 2025: Trial registered